English  |  正體中文  |  简体中文  |  Post-Print筆數 : 27 |  Items with full text/Total items : 113656/144643 (79%)
Visitors : 51718571      Online Users : 604
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://nccur.lib.nccu.edu.tw/handle/140.119/153659


    Title: A Crisis on Patenting of “Ready-to-Use” Oral Liquid Formulations: Azurity Pharms., Inc. v. Alkem Lab’ys Ltd
    Authors: 陳秉訓
    Chen, Ping-Hsun
    Contributors: 科管智財所
    Date: 2024-06
    Issue Date: 2024-09-10 13:07:57 (UTC+8)
    Abstract: In Azurity Pharms., Inc. v. Alkem Lab’ys Ltd., 655 F. Supp. 3d 270 (D. Del. 2023), U.S. Patent Nos. 10,786,482 and 10,918,621 covering Epaned® liquid were invalidated on the ground of obviousness. The claimed invention was an oral liquid formulation of enalapril consisting of enalapril, a buffer, sweetener, a preservative, and water. The district court there found that before the claimed invention, a person of ordinary skill in the art would have combined those ingredients recited in the disputed claims. The appellate court then upheld the district court’s obviousness determination because there was substantial evidence supporting the factual findings. This article is intended to analyze the district court to figure out what constitutes substantial evidence of obviousness. Azurity Pharms., Inc. may block the patenting of “ready-to-use” oral liquid formulations that consist of known excipients. Four aspects can be drawn: (1) it may be obvious to combine ingredient limitations and stability limitations; (2) a buffer limitation with a range of pH values would have been obvious; (3) common excipient limitations would have been obvious; (4) a buffer limitation with a concentration value or range would have been obvious because adjusting the concentration of a chosen buffer to meet the target pH is routine.
    Relation: Biotechnology Law Report, Vol.43, No.3, pp.142-150
    Data Type: article
    DOI 連結: https://doi.org/10.1089/blr.2024.29102.aa
    DOI: 10.1089/blr.2024.29102.aa
    Appears in Collections:[科技管理與智慧財產研究所] 期刊論文

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML74View/Open


    All items in 政大典藏 are protected by copyright, with all rights reserved.


    社群 sharing

    著作權政策宣告 Copyright Announcement
    1.本網站之數位內容為國立政治大學所收錄之機構典藏,無償提供學術研究與公眾教育等公益性使用,惟仍請適度,合理使用本網站之內容,以尊重著作權人之權益。商業上之利用,則請先取得著作權人之授權。
    The digital content of this website is part of National Chengchi University Institutional Repository. It provides free access to academic research and public education for non-commercial use. Please utilize it in a proper and reasonable manner and respect the rights of copyright owners. For commercial use, please obtain authorization from the copyright owner in advance.

    2.本網站之製作,已盡力防止侵害著作權人之權益,如仍發現本網站之數位內容有侵害著作權人權益情事者,請權利人通知本網站維護人員(nccur@nccu.edu.tw),維護人員將立即採取移除該數位著作等補救措施。
    NCCU Institutional Repository is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff(nccur@nccu.edu.tw). We will remove the work from the repository and investigate your claim.
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback